Acasti Pharma | ACST - Stammkapital





Stammkapital Veränderung Datum
Acasti Pharma USD 1000 261.04M 2024-12
Addus HomeCare USD 18.67M 9K 2026-09
Amarin USD 20.81M 13K 2025-12
Cassava Sciences USD 48.31M 0 2026-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Option Care Health USD 149.79M 17K 2026-09
Organigram Holdings CAD 140.98M 4.51M 2026-06
Tilray USD 116.52M 5.01M 2025-09